- Home
- » Tags
- » ARIAD Pharmaceuticals
Top View
- Third-Quarter Biotech Job Picture
- ARIAD Pharmaceuticals, Inc.; Rule 14A-8 No-Action Letter
- FULL NAME Contact Company ID Email 3M Company Suzanne Danielson CC0013 [email protected] 3M Unitek Corporation Vincent Martinez CC0361 [email protected] A-Dec, Inc
- Disclosure Summary
- 2794D051numericlist May 2015.Xlsx
- 02/10/2015 Provider Subsystem Healthcare and Family Services Run Time: 20:51:09 Report Id 2794D051 Page: 01
- Medicaid System (Mmis) Illinois Department of Run Date: 02/10/2015 Provider Subsystem Healthcare and Family Services Run Time: 20:51:09 Report Id 2794D052 Page: 01
- Life Sciences, High Tech, and Clean Energy Companies
- Jazz Pharmaceuticals Plc Proxy Statement 2018 Annual Report Proxy Statement — 2018 Annual Report June 14, 2019
- Modus Health Group Research Coverage Companies and Healthcare Sectors 2017 Healthcare Care Facilities
- Abbott Outbids Biogen for Facet's Multiple Sclerosis Antibody
- Jazz Pharmaceuticals Plc Proxy Statement 2017 Annual Report
- December 2020
- U.S. Pharmaceutical/Biotech Industry Update
- Faculty Disclosure
- 08/06/2016 Provider Subsystem Healthcare and Family Services Run Time: 00:10:55 Report Id 2794D052 Page: 01
- The Activist Report
- Customer Rebate List Covering
- Momelotinib in Myelofibrosis a Phase 1/2, Open-Label Study Evaluating
- CY 2017 CDER Drug and Biologic Calendar Year Priority Approvals As of December 31, 2017
- Launch Or License
- Contract Drugs List Part 1 – Prescription Drugs (A Through D) Page Updated: November 2020
- Jazz Pharmaceuticals
- Bio-Medical, Pharmaceutical, and Medical Device Company Profiles
- 2794D052alphalist May 2015.Xlsx
- Rebateable Manufacturers
- Where Are We Now Post-Ariad?
- Regulators Grant Biogen a Big Win but AB Science Loses Out
- The Story of Ariad Pharmaceuticals, Inc. V. Eli Lilly &
- Manufacturer Abbreviations*
- Conference Call Takeda to Acquire ARIAD Pharmaceuticals Significantly Enhances Takeda's Global Oncology Portfolio
- Policy and Medicine Applicable